GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Reyon Pharmaceutical Co 102460.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

9,380

+0.97%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Reyon Pharmaceutical Co — daily KRX:102460

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Reyon Pharmaceutical Co on TradingView ↗
Market value
₩172.04bn
Last close × shares
Volume
44.2k
Shares, 9 Nov 2026

About Reyon Pharmaceutical Co

Its shares trade on KRX under the ticker 102460.KS. It has been listed since 10 June 2010. In the fiscal year to 31 December 2025, it reported revenue of ₩145.93bn and a net loss of ₩29.63bn. At that date it held total assets of ₩465.10bn and shareholders' equity of ₩220.27bn.

REYON PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-06-10. The Company’s products consist of remedies for circulatory systems, endocrine systems, digestive systems, respiratory systems, urinary systems and nervous systems, as well as eye drops, antibiotics, fever reducers, painkillers, anti-inflammatory drugs, antihistaminic agents, enzyme preparations, arthritis remedies, antitumor drugs and topical anesthetics, among others. The company also produces pharmaceutical raw materials, such as arbekacin sulfate, alibendol, carvedilol, enocitabine, gemcitabine, glimepiride, lamotrigine, meloxicam, oxaliplatin, pioglitazone hydrochloride, ramipril, streptokinase, tacrolimus, thioctic acid, teicoplanin, voglibose and others.

Figures and description from our data supplier, not checked against the company's own report.

More about Reyon Pharmaceutical Co →

Latest on Reyon Pharmaceutical Co

Our reporting

We have not reported on Reyon Pharmaceutical Co yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Reyon Pharmaceutical Co's ticker?

Reyon Pharmaceutical Co trades as 102460.KS on KRX, under ISIN KR7102460003.

What was Reyon Pharmaceutical Co's last closing price?

9,380 on 9 Nov 2026. The figure is in KRW and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.